Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in standardizing antifungal susceptibility tests.

J N Galgiani1

  • 1University of Arizona College of Medicine, Tucson.

Clinics in Laboratory Medicine
|June 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

T-lymphocyte predominance in lesions of canine coccidioidomycosis.

Veterinary pathology·2010
Same author

Coccidioidomycosis complicating solid organ transplantation.

Seminars in respiratory infections·2001
Same author

Dendritic cells pulsed with Coccidioides immitis lysate induce antigen-specific naive T cell activation.

The Journal of infectious diseases·2001
Same author

Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group.

Annals of internal medicine·2000
Same author

The Cryptococcus neoformans gene DHA1 encodes an antigen that elicits a delayed-type hypersensitivity reaction in immune mice.

Infection and immunity·2000
Same author

Genetic transformation of Coccidioides immitis facilitated by Agrobacterium tumefaciens.

The Journal of infectious diseases·2000
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles

Antifungal susceptibility testing is crucial for selecting effective treatments. Reliable in vitro tests correlate with patient outcomes and are expected to become widely available for yeasts soon.

Area of Science:

  • Clinical microbiology
  • Mycology
  • Pharmacology

Background:

  • In vitro antifungal susceptibility testing (AFST) is gaining importance in clinical laboratories.
  • The increasing number of antifungal agents necessitates methods to guide treatment selection.
  • Current efforts focus on standardizing AFST to improve inter-laboratory agreement.

Purpose of the Study:

  • To highlight the growing value of in vitro antifungal susceptibility tests.
  • To emphasize the potential of AFST in improving patient care through personalized treatment selection.
  • To discuss the ongoing efforts towards reliable and standardized antifungal testing methods.

Main Methods:

  • The abstract discusses the concept and growing importance of in vitro antifungal susceptibility testing.

Related Experiment Videos

  • It reviews the accumulating evidence supporting the correlation between in vitro test results and clinical outcomes.
  • It mentions ongoing collaborative efforts to enhance the reproducibility of these tests across different laboratories.

    • Main Results:

    • In vitro antifungal susceptibility tests show significant correlation with treatment results.
    • Standardized testing methods are likely to improve patient care by guiding antifungal drug selection.
    • Reliable testing methods for yeasts are anticipated in the near future.

    Conclusions:

    • In vitro antifungal susceptibility testing is essential for optimizing antifungal therapy.
    • Standardization and validation of these tests will enhance their clinical utility.
    • The development of reliable yeast susceptibility testing is a promising advancement for clinical laboratories.